BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

SUMMIT THERAPEUTICS PLC — Lobbying — Receipts Report

LD-2 disclosure · Registration

SUMMIT THERAPEUTICS PLC

via THE KPM GROUP DC LLC

2nd Quarter (Apr 1 - June 30) · 2020Posted Jul 30, 2020Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: SUMMIT THERAPEUTICS PLC
Description: Biopharmaceutical company; develops medicines to treat infectious diseases
Location: Massachusetts · United States of America

Registrant

Firm: THE KPM GROUP DC LLC
Description: lobby firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
COVID -19 Stimulus Package (domestic manufacturing)
LobbyistsPATROSKI LAWSON · BENJAMIN MASON
Covered position (BENJAMIN MASON): Communications Director; Rep. David Young January 2017 - June 2017

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.